{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:42:49Z","timestamp":1777502569404,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-021-02005-x","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T17:07:38Z","timestamp":1619197658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability"],"prefix":"10.1208","volume":"22","author":[{"given":"Liuhong","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dihuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"5","key":"2005_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1759720X10381432","volume":"2","author":"G Schett","year":"2010","unstructured":"Schett G, Sloan SV, Stevens MR, Schafer P. Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases. Ther Adv Musculoskel. 2010;2(5):271\u20138.","journal-title":"Ther Adv Musculoskel"},{"key":"2005_CR2","volume-title":"US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Guidance for Industry, Clinical Pharmacology and Biopharmaceutics review","author":"FDA","year":"2014","unstructured":"FDA (2014). US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Guidance for Industry, Clinical Pharmacology and Biopharmaceutics review, March 2014."},{"issue":"12","key":"2005_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","volume":"83","author":"P Schafer","year":"2012","unstructured":"Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol. 2012;83(12):1583\u201390.","journal-title":"Biochem Pharmacol"},{"key":"2005_CR4","unstructured":"EMA. Assessment report on Otezla (apremilast). CHMP, EMA. 2014;2014."},{"issue":"1-2","key":"2005_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2005.11.013","volume":"111","author":"J Jinno","year":"2006","unstructured":"Jinno J, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 2006;111(1-2):56\u201364.","journal-title":"J Control Release"},{"key":"2005_CR6","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1039\/C8CE00689J","volume":"20","author":"FY Wang","year":"2018","unstructured":"Wang FY, Zhang Q, Zhang ZY, Gong XY, Wang JR, Mei XF. Solid-state characterization and solubility enhancement of apremilast drug-drug cocrystals. CrystEngComm. 2018;20:5945\u20138.","journal-title":"CrystEngComm."},{"key":"2005_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijpharm.2015.08.062","volume":"494","author":"SR Rudrangi","year":"2015","unstructured":"Rudrangi SR, Trivedi V, Mitchell JC, Wicks SR, Alexander BD. Preparation of olanzapine and methyl-beta-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: an approach to enhance the solubility and dissolution properties. Int J Pharm. 2015;494:408\u201316.","journal-title":"Int J Pharm"},{"issue":"1","key":"2005_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17219\/pim\/99801","volume":"48","author":"JR Madan","year":"2018","unstructured":"Madan JR, Pawar AR, Patil RB, Awasthi R, Dua K. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast. Polim Med. 2018;48(1):17\u201324.","journal-title":"Polim Med"},{"issue":"11","key":"2005_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1517\/17425247.2011.618181","volume":"8","author":"DN Bikiaris","year":"2011","unstructured":"Bikiaris DN. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv. 2011;8(11):1501\u201319.","journal-title":"Expert Opin Drug Deliv"},{"key":"2005_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2015.12.010","volume":"100","author":"A Singh","year":"2016","unstructured":"Singh A, Van den Mooter G. Spray drying formulation of amorphous solid dispersion. Adv Drug Deliv Rev. 2016;100:27\u201350.","journal-title":"Adv Drug Deliv Rev"},{"key":"2005_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1208\/s12248-016-0017-9","volume":"19","author":"J Li","year":"2017","unstructured":"Li J, Patel D, Wang G. Use of spray-dried dispersions in early pharmaceutical development: theoretical and practical challenges. AAPS J. 2017;19:321\u201335.","journal-title":"AAPS J"},{"key":"2005_CR12","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/jps.24541","volume":"104","author":"Y He","year":"2015","unstructured":"He Y, Ho C. Amorphous solid dispersions: utilization and challenges in drug discovery and development. J Pharm Sci. 2015;104:3237\u201358.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2005_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejpb.2007.11.004","volume":"69","author":"S Janssens","year":"2007","unstructured":"Janssens S, Nagels S, Armas H, Autry W, Schepdael A, Van den Mooter G. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm. 2007;69(1):158\u201366.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1-2","key":"2005_CR14","first-page":"79","volume":"251","author":"SC Shin","year":"2003","unstructured":"Shin SC, Kim J. Physicochemical characterization of solid dispersion of furosemide with TPGS. Int\u2002J\u2002Pharm. 2003;251(1-2):79\u201384.","journal-title":"Int\u2002J\u2002Pharm"},{"issue":"2","key":"2005_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","volume":"12","author":"W Chen","year":"2011","unstructured":"Chen W, Yu-Qiang Miao YQ, Fan DJ, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech. 2011;12(2):705\u201311.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2005_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1208\/s12249-011-9722-y","volume":"13","author":"N Aggarwal","year":"2012","unstructured":"Aggarwal N, Goindi S, Mehta SD. Preparation and evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS as penetration enhancer. AAPS PharmSciTech. 2012;13(1):67\u201374.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"2005_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12249-019-1290-6","volume":"20","author":"YK Liu","year":"2019","unstructured":"Liu YK, Sun CY, Li WJ, et al. Preparation and characterization of syringic acid-loaded TPGS liposome with enhanced oral bioavailability and in vivo antioxidant efficiency. AAPS PharmSciTech. 2019;20(3):20\u201398.","journal-title":"AAPS PharmSciTech"},{"key":"2005_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1023\/A:1015000503629","volume":"16","author":"JM Dintaman","year":"1999","unstructured":"Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by d-alphatocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 1999;16:1550\u20136.","journal-title":"Pharm Res"},{"key":"2005_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jps.10395","volume":"92","author":"K Bogman","year":"2003","unstructured":"Bogman K, Erne-Brand F, Alsenz J, Drewe J. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J Pharm Sci. 2003;92:1250\u201361.","journal-title":"J Pharm Sci"},{"key":"2005_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2004.03.001","volume":"278","author":"G Cornaire","year":"2004","unstructured":"Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004;278:119\u201331.","journal-title":"Int J Pharm"},{"key":"2005_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","volume":"16","author":"BD Rege","year":"2002","unstructured":"Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 2002;16:237\u201346.","journal-title":"Eur J Pharm Sci"},{"issue":"1-2","key":"2005_CR22","first-page":"547","volume":"528","author":"M Alhijjaj","year":"2017","unstructured":"Alhijjaj M, Belton P, Qi S. A multi-technique characterization of the stability of surfactant containing solid dispersions based buccal patches prepared by hot melt injection moulding. Int\u2002J\u2002Pharm. 2017;528(1-2):547\u201362.","journal-title":"Int\u2002J\u2002Pharm"},{"issue":"5","key":"2005_CR23","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.5012\/bkcs.2011.32.5.1587","volume":"32","author":"JS Ahn","year":"2011","unstructured":"Ahn JS, Kim KM, Ko CY, Kang JS. Absorption enhancer and polymer (Vitamin E TPGS and PVP K29) by solid dispersion improve dissolution and bioavailability of eprosartan mesylate. Bull Kor Chem Soc. 2011;32(5):1587\u201392.","journal-title":"Bull Kor Chem Soc"},{"key":"2005_CR24","first-page":"458","volume":"473","author":"YC Chen","year":"2014","unstructured":"Chen YC, Ho HO, Chiou JD, Sheu MT. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods. Int\u2002J\u2002Pharm. 2014;473:458\u201368.","journal-title":"Int\u2002J\u2002Pharm."},{"key":"2005_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1208\/s12249-018-1216-8","volume":"20","author":"X Xue","year":"2019","unstructured":"Xue X, Chen GG, Xu XQ, et al. A combined utilization of plasdone-S630 and HPMCAS-HF in ziprasidone hydrochloride solid dispersion by hot-melt extrusion to enhance the oral bioavailability and no food effect. AAPS PharmSciTech. 2019;20:37\u201348.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"2005_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3109\/03639040903449720","volume":"36","author":"HB He","year":"2010","unstructured":"He HB, Yang R, Tang X. In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm. 2010;36(6):681\u20137.","journal-title":"Drug Dev Ind Pharm"},{"key":"2005_CR27","doi-asserted-by":"crossref","unstructured":"Fule RA, Meer TS, Sav AR, Amin PD. Artemether-soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristics. Aust J Pharm. 2013:1\u201315.","DOI":"10.1155\/2013\/151432"},{"issue":"4-5","key":"2005_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ejps.2008.05.005","volume":"34","author":"C Goddeeris","year":"2008","unstructured":"Goddeeris C, Willems T, Van den Mooter G. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Eur J Pharm Sci. 2008;34(4-5):293\u2013302.","journal-title":"Eur J Pharm Sci"},{"key":"2005_CR29","doi-asserted-by":"crossref","unstructured":"Hou HH, Rajesh A, Pandya KM, et al. Impact of method of preparation of amorphous solid dispersions on mechanical properties: comparison of coprecipitation and spray drying. J Pharm Sci. 2019;(108):870\u20139.","DOI":"10.1016\/j.xphs.2018.09.008"},{"key":"2005_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1208\/s12249-019-1392-1","volume":"20","author":"YC Lee","year":"2019","unstructured":"Lee YC, McNevin M, Ikeda C. Combination of colloidal silicon dioxide with spray-dried solid dispersion to facilitate discharge from an agitated dryer. AAPS PharmSciTech. 2019;20:182\u201398.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"2005_CR31","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1208\/s12249-018-1082-4","volume":"19","author":"TT Peng","year":"2018","unstructured":"Peng TT, She YJ, Wu CB, et al. Influence of polymers on the physical and chemical stability of spray-dried amorphous solid dispersion: dipyridamole degradation induced by enteric polymers. AAPS PharmSciTech. 2018;19(6):2620\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"2005_CR32","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.3390\/molecules20069496","volume":"20","author":"Y Cho","year":"2015","unstructured":"Cho Y, Ha ES, Baek IN, et al. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit\u00ae E. Molecules. 2015;20:9496\u2013509.","journal-title":"Molecules."},{"issue":"1-2","key":"2005_CR33","first-page":"424","volume":"441","author":"N Marasinia","year":"2013","unstructured":"Marasinia N, Trana TH, Poudela BK, et al. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Int\u2002J\u2002Pharm. 2013;441(1-2):424\u201332.","journal-title":"Int\u2002J\u2002Pharm"},{"issue":"2","key":"2005_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/mp5006245","volume":"12","author":"J Chen","year":"2015","unstructured":"Chen J, Ormes JD, Higgins JD, Taylor LS. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles. Mol Pharm. 2015;12(2):533\u201341.","journal-title":"Mol Pharm"},{"issue":"7","key":"2005_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3109\/03639045.2012.723218","volume":"39","author":"DJ Jang","year":"2013","unstructured":"Jang DJ, Sim T, Oh E. Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption. Drug Dev Ind Pharm. 2013;39(7):1133\u201341.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"2005_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ejpb.2008.07.006","volume":"70","author":"C Goddeeris","year":"2008","unstructured":"Goddeeris C, Willems T, Houthoofd K, Martens JA, Van den Mooter G. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersions with TPGS 1000 and Eudragit E100. Eur J Pharm Biopharm. 2008;70(3):861\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"2005_CR37","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/molecules21101386","volume":"21","author":"IS Song","year":"2016","unstructured":"Song IS, Cha JS, Choi MK. Characterization, in vivo and in vitro evaluation of solid dispersions of curcumin containing D-\u03b1-tocopheryl polyethylene glycol 1000 succinate and mannitol. Molecules. 2016;21(10):1386\u2013401.","journal-title":"Molecules."},{"issue":"2","key":"2005_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics10020053","volume":"10","author":"DS Feng","year":"2018","unstructured":"Feng DS, Peng TT, Huang ZW, et al. Polymer-surfactant system based amorphous solid dispersion: precipitation inhibition and bioavailability enhancement of itraconazole. Pharmaceutics. 2018;10(2):53\u201367.","journal-title":"Pharmaceutics."},{"issue":"2","key":"2005_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4155\/fmc.09.166","volume":"2","author":"M Moneghini","year":"2010","unstructured":"Moneghini M, Zordi ND, Solinas D, Macchiavelli S, Princivalle F. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology. Future Med Chem. 2010;2(2):237\u201346.","journal-title":"Future Med Chem"},{"key":"2005_CR40","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.xphs.2018.01.016","volume":"107","author":"D Hurley","year":"2018","unstructured":"Hurley D, Potter CB, Walker GM, Clement L. Higginbotham. Investigation of ethylene oxide-co-propylene oxide for dissolution enhancement of hot-melt extruded solid dispersions. J Pharm Sci. 2018;107:1372\u201382.","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"2005_CR41","first-page":"306","volume":"465","author":"ZH Zhang","year":"2014","unstructured":"Zhang ZH, Chen Y, Deng J, et al. Solid dispersions of berberine-phospholipid complex\/TPGS1000\/SiO2: preparation, characterization and invivo studies. Int\u2002J\u2002Pharm. 2014;465(1-2):306\u201316.","journal-title":"Int\u2002J\u2002Pharm"},{"key":"2005_CR42","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.xphs.2019.11.020","volume":"109","author":"WL Fan","year":"2020","unstructured":"Fan WL, Zhang XY, Zhu WJ, Di LQ. The preparation of curcumin sustained-release solid dispersion by hot-melt extrusion-II. Optimization of preparation process and evaluation in vitro and in vivo. J Pharm Sci. 2020;109:1253\u201360.","journal-title":"J Pharm Sci"},{"issue":"2","key":"2005_CR43","first-page":"89","volume":"8","author":"AB Mohd","year":"2016","unstructured":"Mohd AB, Vemula SK. Formulation and pharmacokinetics of vitamin E TPGS melt dispersion granules: an approach to improve oral delivery of flurbiprofen. J Bioequivalence Bioavailab. 2016;8(2):89\u201394.","journal-title":"J Bioequivalence Bioavailab"},{"issue":"1","key":"2005_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijpharm.2016.07.006","volume":"511","author":"DS Kim","year":"2016","unstructured":"Kim DS, Choi JS, Kim DW, et al. Comparison of solvent-wetted and kneaded L-sulpiride-loaded solid dispersions: powder characterization and in vivo evaluation. Int J Pharm. 2016;511(1):351\u20138.","journal-title":"Int J Pharm"},{"issue":"4","key":"2005_CR45","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/mp5008629","volume":"12","author":"T Andey","year":"2015","unstructured":"Andey T, Sudhakar G, Marepally S, Patel A, Banerjee R, Singh M. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation. Mol Pharm. 2015;12(4):1105\u201320.","journal-title":"Mol Pharm"}],"updated-by":[{"DOI":"10.1208\/s12249-021-02046-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000}}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-02005-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T16:06:39Z","timestamp":1666886799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-02005-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-02005-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1208\/s12249-021-02046-2","URL":"https:\/\/doi.org\/10.1208\/s12249-021-02046-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"142"}}